New shares first day | Dano Medicine-B (06872.HK) was listed for trading for the first time, opening with a 98.15% increase in the morning. The core product Lifutonizole is expected to be approved by the end of the year.

According to the Citadel Financial App, Deno Pharmaceutical-B (06872.HK) has been listed for the first time. The announcement shows that the price per share is 75.7 Hong Kong dollars, with a total issue of 8.856 million shares, and 50 shares per lot. The net proceeds are approximately 558 million Hong Kong dollars. As of the time of writing, the price has increased by 98.15% to 150 Hong Kong dollars, with a trading volume of 179 million Hong Kong dollars.